NEW YORK (
) hit a new 52-week high Thursday as it is currently trading at $27.17, above its previous 52-week high of $27.12 with 88,625 shares traded as of 2:30 p.m. ET. Average volume has been 226,300 shares over the past 30 days.
Hi-Tech Pharmacal has a market cap of $336.1 million and is part of the
industry. Shares are up 6.3% year to date as of the close of trading on Wednesday.
Hi-Tech Pharmacal Co., Inc. develops, manufactures, markets, and sells generic, prescription, over-the-counter (OTC), and nutritional products in liquid and semisolid dosage forms in the United States. The company has a P/E ratio of 9.8, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 16.4.
- Practice your HITK trading strategies and win cash in our stock game.
TheStreet Ratings rates Hi-Tech Pharmacal as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, growth in earnings per share and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full
52-week high stocks
or get investment ideas from our